(Journal Article): Spotlight on Ethnomedicine: Usability of Sutherlandia Frutescens in the Treatment of Diabetes
 
Sia C (Department of Immunology, United Biomedical Inc., 25 Davids Drive, Hauppage, New York 11788, USA, csia@mail.ubiasia.com.tw )
 
IN: Rev Diabetic Stud 2004; 1(3):145-149
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: n/a

TYPE OF PUBLICATION: Review

REFERENCES:

1. Van Wyk BE, Van Oudtshoorn B, Gericke N. Medicinal plants of South Africa. 2nd edition, Briza Publications, Pretoria 2002.
2. Fernandes AC, Cromarty AD, Albrecht C, Jansen van Rensburg CE. The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol 2004, 95(1):1-5.
3. Tai J, Cheung S, Chan E, Hasman D. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines, J Ethnopharmacology 2004. 93:9-19.
4. Ojewole JA. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods Find Exp Clin Pharmacol 2004, 26(6):409-416.
5. Swaffar DS, Ang CY, Desai PB, Rosenthal GA. Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine, Cancer Res 1994. 54(23):6045-6048.
6. Rosenthal GA. L-canaline: a potent antimetabolite and anti-cancer agent from leguminous plants. Life Sci 1997. 60(19):1635-1641.
7. Miersch J, Grancharov K, Pajpanova T, Tabakova S, Stoev S, Krauss GJ, Golovinsky E. Synthesis and biological activity of canavanine hydrazide derivatives. Amino Acids 2000. 18(1):41-59.
8. Yamamoto N, Mueller-Lantzsch N, zur-Hausen H. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine. Int J Cancer 1980. 25(4):439-443.
9. Bence AK, Worthen DR, Adams VR, Crooks PA. The antiproliferative and immunotoxic effects of L-canavanine and L-canaline. Anticancer Drugs 2002. 13(3):313-320.
10. Torre D, Pugliese A, Speranza F. Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect Dis 2002. 2(5):273-280.
11. Singh RK, Pandey BL, Tripathi M, Pandey VB. Anti-inflammatory effect of (+)-pinitol. Fitoterapia. 2001. 72(2):168-170.
12. Ortega A. A new role for GABA: inhibition of tumor cell migration. Trends Pharmacol Sci 2003. 24:151-154.
13. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004. 29(6):1050-1062.
14. WHO Press release. WHO launches the first global strategy on traditional and alternative medicine. WHO/38, May 2002.
15. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterisation of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and ß cell destruction in NOD mice. Diabetes 1994. 43:667-675.
16. Kay TW, Chaplin HL, Parker JL, Stephens LA, Thomas HE. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. Res Immunol 1997. 148:320-327.
17. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998. 55:1139-1149.
18. Lotz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S. Protection of insulin-producing RINm5F cells against cytokine-mediated cytoxicity through overexpression of antioxidant enzymes. Diabetes 2000. 49:1123-1130.
19. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 2002. 51:347-355.
20. Porte D Jr. Banting Lecture 1991: beta-cells in type 2 diabetes mellitus. Diabetes 1991. 40:166-180.
21. Myint T, Hoshi S, Ookawara T, Miyazawa N, Suzuki K, Taniguchi N. Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti-hexito-ysine IgG. Biochem Biophys Acta 1995. 1272:73-79.
22. Tajiri Y, Moller C, Grill V. Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits beta-cell function. Endocrinology 1997. 138:273-280.
23. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999. 48:927-932.
24. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996. 320:855-863.
25. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 1997. 99:144-150.
26. Bates SH, Jones RB, Baily CJ. Insulin like effect of pinitol. Br J Pharmacol 2000. 130(8):1944-1948.
27. Davies A, Christensen M, Horowitz JF, Klein S, Hellerstein MK, Ostlund Jr RE. Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 2000. 23:1000-1005.
28. Medline Plus. A service of the U.S. NLM and NIH. Tolazamide. http://www.nlm.nih.gov/medlineplus/druginfo/ medmaster/a682482.html. Last revise: 01/01/2003.
29. Li Y, Peng G, Li Q, Wen S, Huang TH, Roufogalis BD, Yamahara J. Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci 2004. 75(14):1735-46.
30. Vitor RF, Mota-Filipe H, Teixeira G, Borges C, Rodrigues AI, Teixeira A, Paulo A. Flavonoids of an extract of Pterospartum tridentatum showing endothelial protection against oxidative injury. J Ethnopharmacol 2004. 93(2-3):363-370.